IT0005604555 20240902 21 (I10320) News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference PR Newswire BOSTON, May 7, 2024...

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements PR...

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]